Gene Expression Signatures That Predict Outcome of Tamoxifen-Treated Estrogen Receptor-Positive, High-Risk, Primary Breast Cancer Patients: A DBCG Study

BACKGROUND: Tamoxifen significantly improves outcome for estrogen receptor-positive (ER+) breast cancer, but the 15-year recurrence rate remains 30%. The aim of this study was to identify gene profiles that accurately predicted the outcome of ER+ breast cancer patients who received adjuvant Tamoxife...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyng, Maria B., Lænkholm, Anne-Vibeke, Tan, Qihua, Vach, Werner, Gravgaard, Karina H., Knoop, Ann, Ditzel, Henrik J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546921/
https://www.ncbi.nlm.nih.gov/pubmed/23342080
http://dx.doi.org/10.1371/journal.pone.0054078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546921/
https://www.ncbi.nlm.nih.gov/pubmed/23342080
http://dx.doi.org/10.1371/journal.pone.0054078

Ejemplares similares